Results 231 to 240 of about 7,056,691 (346)

E-health supported referral for patients with breast abnormalities at primary healthcare facilities in Ethiopia: protocol for a cluster-randomised controlled trial. [PDF]

Trials
Getachew E, Gizaw M, Anberber E, Shita A, Destaw A, Rossner SS, Tesfaw A, Addissie A, Kantelhardt EJ, Kroeber ES, Getachew S.   +10 more
europepmc   +1 more source

Safety protocols for citizen science demonstrations

Safety protocols for citizen science demonstrations (M6, METNO)
openaire   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Effect of transcutaneous auricular vagus nerve stimulation on perioperative psychological symptoms in patients undergoing elective thoracoscopic pneumonectomy under general anaesthesia: study protocol for a single-centre, prospective, randomised, double-blind, controlled study. [PDF]

BMJ Open
Sun Z, Wang Y, Chen J, Lin Y, Ma T, Zhou M, Li P, Liu J, Zhao W, Xiong X, Tan W, Tao M, Cao JL, Liu H.   +13 more
europepmc   +1 more source

Current Protocols in Protein Science

, 2018
openaire   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Adherence to Protocol Registration Among Systematic Reviews on Photobiomodulation: A Meta-Research Study. [PDF]

J Eval Clin Pract
Santos GM, Lopes GCM, Martins Sá KM, da Rocha Soares GA, Gonçalves MLL, Bussadori SK, Santos EM, Martimbianco ALC.   +7 more
europepmc   +1 more source

Stimulating training and access to HIV research experiences (STAR program): a protocol for a crowdsourced, project-based, implementation science training program using mixed-methods design [PDF]

Juliet Iwelunmor, Idia B. Thurston, Collins O. Airhihenbuwa, Weiming Tang, Ucheoma Nwaozuru, Onyekachukwu Anikamadu, David Oladele, Bryce Puesta Takenaka, Khadijah Ameen, Olufunto A. Olusanya, Temitope Ojo, Joseph D. Tucker   +11 more
openalex   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source